| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,876 |
2,454 |
$217K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,057 |
930 |
$48K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
399 |
361 |
$30K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
322 |
201 |
$25K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
177 |
167 |
$24K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
290 |
256 |
$22K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
227 |
211 |
$19K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
378 |
359 |
$17K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
886 |
820 |
$17K |
| 96127 |
|
465 |
407 |
$10K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
98 |
89 |
$7K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
123 |
111 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
83 |
81 |
$6K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
71 |
65 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
113 |
86 |
$2K |
| 87081 |
|
59 |
43 |
$577.16 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
18 |
18 |
$563.40 |
| 0071A |
|
14 |
14 |
$560.00 |
| 91307 |
|
15 |
14 |
$0.02 |
| 99072 |
|
204 |
166 |
$0.00 |